ARMP (Armata Pharmaceuticals, Inc. Common Stock) Stock Analysis - Politician Trades

Armata Pharmaceuticals, Inc. Common Stock (ARMP) is a publicly traded Healthcare sector company. As of May 21, 2026, ARMP trades at $8.18 with a market cap of $279.00M and a P/E ratio of -1.71. ARMP moved -3.78% today. Year to date, ARMP is +27.87%; over the trailing twelve months it is +260.89%. Its 52-week range spans $0.90 to $16.34. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces ARMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ARMP stock?

Rallies tracks politician and congressional stock disclosures for ARMP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ARMP Key Metrics

Key financial metrics for ARMP
MetricValue
Price$8.18
Market Cap$279.00M
P/E Ratio-1.71
EPS$-4.80
Dividend Yield0.00%
52-Week High$16.34
52-Week Low$0.90
Volume210
Avg Volume0
Revenue (TTM)$4.90M
Net Income$-173.80M
Gross Margin0.00%

Latest ARMP News

ARMP Analyst Consensus

2 analysts cover ARMP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.

Common questions about ARMP

Which politicians traded ARMP stock?
Rallies tracks politician and congressional stock disclosures for ARMP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ARMP?
Yes. Rallies tracks politician and congressional stock disclosures for ARMP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ARMP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARMP. It does not provide personalized investment advice.
ARMP

ARMP